Voyager Therapeutics rises after Citigroup starts coverage with 'buy'

Voyager Therapeutics

02/12/2024 12:55

** Biotech company Voyager Therapeutics'  VYGR.O  shares
rise about 1% to $6.92 premarket
    ** Citigroup starts coverage on stock with "buy" rating and
PT at $12
    ** Last week, Wedbush analyst Yun Zhong also started
coverage on stock with "outperform" rating and PT at $11
    ** All ten brokerages rate the stock "buy" or higher; median
PT on the stock is $18 - LSEG
    ** As of last close, stock down 18.7% YTD

 (Reporting by Jaiveer Singh Shekhawat in Bengaluru)
 ((JaiveerSingh.Shekhawat@thomsonreuters.com;))